Page 149 - 80_01
P. 149

Luis	
  García-­-Sevillano	
  

	
  

          Epidemiological	
   Investigation	
   of	
   Rheumatoid	
   Arthritis	
   and	
   the	
   Swedish	
   Rheumatology	
  
          Register	
  cohorts.	
  Arthritis	
  Rheum	
  63,	
  26-­-36	
  (2011).	
  
     27.	
   Olsson,	
   A.R.;	
   Skogh,	
   T.;	
   Axelson,	
   O.;	
   Wingren,	
   G.	
   Occupations	
   and	
   exposures	
   in	
   the	
   work	
  
          environment	
   as	
   determinants	
   for	
   rheumatoid	
   arthritis.	
   Occup	
   Environ	
   Med	
   61,	
   233-­-238	
  
          (2004).	
  
     28.	
   Jin,	
   Z.;	
   Xiang,	
   C.;	
   Cai,	
   Q.;	
   Wei,	
   X.;	
   He,	
   J.	
   Alcohol	
   consumption	
   as	
   a	
   preventive	
   factor	
   for	
  
          developing	
   rheumatoid	
   arthritis:	
   a	
   dose-­-response	
   meta-­-analysis	
   of	
   prospective	
   studies.	
  
          Ann	
   RheumDis	
   (2013).	
   Disponible	
   en:	
   http://dx.doi.org/10.1136/annrheumdis-­-2013-­-
          203323	
  
     29.	
   Agmon-­-Levin,	
   N.;Theodor,	
   E.;Segal,	
   R.	
   M.;	
   Shoenfeld,	
   Y.Vitamin	
   D	
   in	
   systemic	
   and	
   organ-­-
          specific	
   autoimmune	
   diseases.	
   Clin	
   Rev	
   Allergy	
   Immunol	
   45,	
   256-­-266	
   (2013).	
   Disponible	
  
          en:	
  http://dx.doi.org/10.1007/s12016-­-012-­-8342-­-y	
  
     30.	
   Feser,	
   M.;	
   Derber,	
   L.	
   A.;	
   Deane,	
   K.	
   D.;	
   Lezotte,	
   D.	
   C.;	
   Weisman,	
   M.	
   H.;	
   Buckner,	
   J.	
   H.;	
   et	
   al.	
  
          Plasma	
  25,OH	
  vitamin	
  D	
  concentrations	
  are	
  not	
  associated	
  with	
  rheumatoid	
  arthritis	
  (RA)-­-
          related	
   autoantibodies	
   in	
   individuals	
   at	
   elevated	
   risk	
   for	
   RA.	
   J	
   Rheumatol36,	
   943-­-946	
  
          (2009).	
  
     31.	
   Calviello,	
   G.;	
   Su,H.	
   M.;	
   Weylandt,	
   K.	
   H.;	
   Fasano,	
   E.;	
   Serini,	
   S.;	
   Cittadini,	
   A.	
   Experimental	
  
          Evidence	
   of	
   ??-­-3	
   Polyunsaturated	
   Fatty	
   Acid	
   Modulation	
   of	
   Inflammatory	
   Cytokines	
   and	
  
          Bioactive	
   Lipid	
   Mediators:	
   Their	
   Potential	
   Role	
   in	
   Inflammatory,	
   Neurodegenerative,	
   and	
  
          Neoplastic	
   Diseases.	
   Biomed	
   Res	
   Int	
   743171,	
   (2013).	
   Disponible	
   en:	
  
          http://dx.doi.org/10.1155/2013/743171	
  
     32.	
   Miles,	
   E.	
   A.;	
   Calder,	
   P.	
   C.	
   Influence	
   of	
   marine	
   n-­-3	
   polyunsaturated	
   fatty	
   acids	
   on	
   immune	
  
          function	
   and	
   a	
   systematic	
   review	
   of	
   their	
   effects	
   on	
   clinical	
   outcomes	
   in	
   rheumatoid	
  
          arthritis.	
   Br	
   J	
   Nutr	
   Jun	
   107	
   (Suppl	
   S2),	
   171-­-184	
   (2012).	
   Disponible	
   en:	
  
          http://dx.doi.org/10.1017/S0007114512001560.	
  
     33.	
   Stamp,	
   L.	
   K.;	
   James,	
   M.	
   J.;	
   Cleland,	
   L.	
   G.	
   Diet	
   and	
   rheumatoid	
   arthritis:	
   a	
   review	
   of	
   the	
  
          literature.	
  Semin	
  Arthritis	
  Rheum	
  35,77-­-94	
  (2005).	
  
     34.	
   Costenbader,	
   K.H.;	
   Kang,	
   J.H.;	
   Karlson,	
   E.	
   W.	
   Antioxidant	
   intake	
   and	
   risks	
   of	
   rheumatoid	
  
          arthritis	
   and	
   systemic	
   lupus	
   erythematosus	
   in	
   women.	
   Am	
   J	
   Epidemiol	
   172,205-­-216	
  
          (2010).	
  
     35.	
  Scher,	
  J.U.;	
  Ubeda,	
  C.;	
  Equinda,	
  M.;	
  Khanin,	
  R.;	
  Buischi,	
  Y.;	
  Viale,	
  A.;	
  et	
  al.	
  Periodontal	
  disease	
  
          and	
   the	
   oral	
   microbiota	
   in	
   new-­-onset	
   rheumatoid	
   arthritis.	
   Arthritis	
   Rheum	
   64,	
   3083-­-
          3094	
  (2012).	
  
     36.	
   Mangat,	
   P.;	
   Wegner,	
   N.;	
   Venables,	
   P.J.;	
   Potempa,	
   J.	
   Bacterial	
   and	
   human	
   peptidy	
   largin	
   in	
  
          edeiminases:	
   targets	
   for	
   inhibiting	
   the	
   autoimmune	
   response	
   in	
   rheumatoid	
   arthritis?	
  
          Arthritis	
   Res	
   Ther	
   12,	
   209(2010).	
   Disponible	
   en:	
   http://arthritis-­-
          research.com/content/12/3/209.	
  
     37.	
  Hitchon,	
  C.	
  A.;	
  El-­-Gabalawy,	
  H.S.	
  Infection	
  and	
  rheumatoid	
  arthritis:	
  still	
  an	
  open	
  question.	
  
          CurrOpinRheumatol	
  23,	
  352-­-357	
  (2011).	
  
     38.	
  Van	
  den	
  Oever,	
  I.	
  A.;	
  van	
  Sijl,	
  A.	
  M.;	
  Nurmohamed,	
  M.	
  T.Management	
  of	
  cardiovascular	
  risk	
  
          in	
   patients	
   with	
   rheumatoid	
   arthritis:	
   evidence	
   and	
   expert	
   opinion.	
   Ther	
   Adv	
  
          Musculoskelet	
   Dis	
   5,	
   166-­-81	
   (2013).	
   Disponible	
   en:	
  
          http://dx.doi.org/10.1177/1759720X13491025.	
  
     39.	
   Ajeganova,	
   S.;	
   Andersson,	
   M.	
   L.	
   &Hafström,	
   I.	
   Obesity	
   is	
   associated	
   with	
   worse	
   disease	
  
          severity	
   in	
   rheumatoid	
   arthritis	
   as	
   well	
   as	
   with	
   co-­-morbidities—a	
   long-­-term	
   follow-­-up	
  
          from	
   disease	
   onset.	
   Arthritis	
   Care	
   Res	
   65,	
   78-­-87	
   (2013).	
   Disponible	
  
          en:http://dx.doi.org/10.1002/acr.21710.	
  
     40.	
   Wolfe,	
   F.;	
   Michaud,	
   K.	
   Effect	
   of	
   body	
   mass	
   index	
   on	
   mortality	
   and	
   clinical	
   status	
   in	
  
          rheumatoid	
  arthritis.	
  Arthritis	
  Care	
  Res	
  64,	
  1471-­-1479	
  (2012).	
  
     41.	
   Stavropoulos-­-Kalinoglou,	
   A.;	
   Metsios,	
   G.	
   S.;	
   Panoulas,	
   V.	
   F.;	
   Nightingale,	
   P.;	
   Koutedakis,Y.;	
  
          Kitas,	
   G.	
   D.	
   Anti-­-tumour	
   necrosis	
   factor	
   a	
   therapy	
   improves	
   insulin	
   sensitivity	
   in	
   normal-­-
          weight	
   but	
   not	
   in	
   obese	
   patients	
   with	
   rheumatoid	
   arthritis.	
   Arthritis	
   Res	
   Ther	
   14,	
   R160	
  
          (2012).Disponible	
  en:	
  http://arthritis-­-research.com/content/14/4/R160.	
  
     42.	
  Isaacs,	
  J.	
  D.	
  The	
  changing	
  face	
  of	
  rheumatoid	
  arthritis:	
  sustained	
  remission	
  for	
  all?.	
  Nat	
  Rev	
  
          Inmunol10,	
  605-­-611	
  (2010).	
  
     43.	
   Goronzy,	
   J.	
   J.;	
   Weyand,	
   C.	
   M.	
   Developments	
   in	
   the	
   scientific	
   understanding	
   of	
   rheumatoid	
  
          arthritis.	
   Arthritis	
   Res	
   Ther	
   11,	
   249	
   (2009).	
   Disponible	
   en:	
   http://arthritis-­-
          research.com/content/11/5/249.	
  

146	
  

	
  
   144   145   146   147   148   149   150   151   152   153   154